Pricing Log in Create free account

Biorestorative Therapies, Inc. (BRTX) vs Enlivex Ltd. (ENLV)

Biorestorative Therapies, Inc. and Enlivex Ltd. are both Biotechnology companies. Biorestorative Therapies, Inc. and Enlivex Ltd. are of similar size ($2.1M and $2.0M). Biorestorative Therapies, Inc. has negative trailing earnings, so its P/E is not meaningful; Enlivex Ltd. trades at 0.0×. Enlivex Ltd. has the higher net margin (0.00% vs −3,089.3%) and the lower return on invested capital (−5.85% vs 0.00%). Across the 15 metrics below, Enlivex Ltd. leads on 10 and Biorestorative Therapies, Inc. on 5.

Valuation

Metric BRTX ENLV Biotechnology median
P/E n/m 0.00 10.60
P/S 3.67 n/m 9.40
P/B 0.43 0.00 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.15 240.80 0.66
EV/Sales (5.84) n/m 9.02
Earnings yield (1,445.95%) 657,517.54% (32.88%)
Free cash flow yield (999.27%) (798.45%) (23.13%)

Profitability

Metric BRTX ENLV Biotechnology median
Gross margin 92.09% 0.00% 68.51%
Operating margin (3,974.66%) 0.00% 0.00%
Net margin (3,089.30%) 0.00% 0.00%
Free cash flow margin (3,302.04%) 0.00% 0.00%
Return on equity (241.50%) 159.77% (51.96%)
Return on assets (147.75%) 127.16% (46.06%)
Return on invested capital 0.00% (5.85%) 0.00%

Growth

Metric BRTX ENLV Biotechnology median
Revenue growth (TTM) (8.47%) — 6.76%
EPS growth (last fiscal year) (36.21%) 3,580.76% 29.88%
Revenue growth, 5-year CAGR 36.11% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BRTX ENLV Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.35 119.39 4.97
Net debt to EBITDA 0.19 118.29 1.01

Dividend

Metric BRTX ENLV Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BRTX ENLV Biotechnology median
Market cap 2.09m 1.95m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack